Search Results - "Van Der Werf, Tjip S"

Refine Results
  1. 1

    Therapeutic vaccines for tuberculosis—A systematic review by Gröschel, Matthias I, Prabowo, Satria A, Cardona, Père-Joan, Stanford, John L, Werf, Tjip S van der

    Published in Vaccine (30-05-2014)
    “…Highlights • We identified 5 potential therapeutic TB vaccines—Mycobacterium vaccae, RUTI, Mycobacterium smegmatis, Mycobacterium indicus pranii and V5. • M…”
    Get full text
    Journal Article
  2. 2

    Sensitivity and specificity of routine diagnostic work-up for tuberculosis in lung clinics in Yogyakarta, Indonesia: a cohort study by Saktiawati, Antonia Morita I, Subronto, Yanri W, Stienstra, Ymkje, Sumardi, Supit, Fabiola, van der Werf, Tjip S

    Published in BMC public health (02-04-2019)
    “…Establishing a correct diagnosis is challenging. We aimed to investigate the sensitivity and specificity of routine tuberculosis (TB) diagnostic work-up in…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Voriconazole metabolism is influenced by severe inflammation: a prospective study by Veringa, Anette, Ter Avest, Mendy, Span, Lambert F R, van den Heuvel, Edwin R, Touw, Daan J, Zijlstra, Jan G, Kosterink, Jos G W, van der Werf, Tjip S, Alffenaar, Jan-Willem C

    Published in Journal of antimicrobial chemotherapy (01-01-2017)
    “…During an infection or inflammation, several drug-metabolizing enzymes in the liver are down-regulated, including cytochrome P450 iso-enzymes. Since…”
    Get full text
    Journal Article
  5. 5

    Global Epidemiology of Buruli Ulcer, 2010-2017, and Analysis of 2014 WHO Programmatic Targets by Omansen, Till F, Erbowor-Becksen, Alfred, Yotsu, Rie, van der Werf, Tjip S, Tiendrebeogo, Alexander, Grout, Lise, Asiedu, Kingsley

    Published in Emerging infectious diseases (01-12-2019)
    “…Buruli ulcer is a neglected tropical disease caused by Myocobacterium ulcerans; it manifests as a skin lesion, nodule, or ulcer that can be extensive and…”
    Get full text
    Journal Article
  6. 6

    Mycobacterium ulcerans disease by VAN DER WERF, Tjip S, STIENSTRA, Ymkje, ASIEDU, Kingsley, JOHNSON, R. Christian, PHILLIPS, Richard, ADJEI, Ohene, FLEISCHEJ, Bernhard, WANSBROUGH-JONES, Mark H, JOHNSON, Paul D. R, PORTAELS, Francoise, VAN DER GRAAF, Winene T. A

    Published in Bulletin of the World Health Organization (01-10-2005)
    “…Mycobacterium ulcerans disease (Buruli ulcer) is an important health problem in several west African countries. It is prevalent in scattered foci around the…”
    Get full text
    Journal Article
  7. 7

    Pharmacokinetics of extended-release clarithromycin in patients with Mycobacterium ulcerans infection by Klis, Sandor-Adrian, Stienstra, Ymkje, Abass, Kabiru M., Abottsi, Justice, Mireku, Samuel O., Alffenaar, Jan-Willem, van der Werf, Tjip S.

    Published in Scientific reports (28-08-2024)
    “…Clarithromycin extended-release (CLA-ER) was used as companion drug to rifampicin (RIF) for Mycobacterium ulcerans infection in the intervention arm of a WHO…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Pathogen-based precision medicine for drug-resistant tuberculosis by Gröschel, Matthias I, Walker, Timothy M, van der Werf, Tjip S, Lange, Christoph, Niemann, Stefan, Merker, Matthias

    Published in PLoS pathogens (01-10-2018)
    “…[...]mutations can be used to predict different treatment outcomes. [...]by also considering phylogenetic benign mutations that do not confer resistance, a…”
    Get full text
    Journal Article
  10. 10

    Sensitivity and specificity of an electronic nose in diagnosing pulmonary tuberculosis among patients with suspected tuberculosis by Saktiawati, Antonia M I, Stienstra, Ymkje, Subronto, Yanri W, Rintiswati, Ning, Sumardi, Gerritsen, Jan-Willem, Oord, Henny, Akkerman, Onno W, van der Werf, Tjip S

    Published in PloS one (13-06-2019)
    “…To investigate the potency of a hand-held point-of-care electronic-nose to diagnose pulmonary tuberculosis (PTB) among those suspected of PTB. Setting: Lung…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Immunology in tuberculosis: challenges in monitoring of disease activity and identifying correlates of protection by van Altena, Richard, Duggirala, Sridevi, Gröschel, Matthias I P, van der Werf, Tjip S

    Published in Current pharmaceutical design (01-09-2011)
    “…Humans have always lived with tubercle bacilli. Host susceptibility both inherited and acquired determines whether an individual infected with Mycobacterium…”
    Get more information
    Journal Article
  13. 13

    Delayed versus standard assessment for excision surgery in patients with Buruli ulcer in Benin: a randomised controlled trial by Wadagni, Akpeedje C, Barogui, Yves T, Johnson, Roch C, Sopoh, Ghislain E, Affolabi, Dissou, van der Werf, Tjip S, de Zeeuw, Janine, Kleinnijenhuis, Johanneke, Stienstra, Ymkje

    Published in The Lancet infectious diseases (01-06-2018)
    “…Surgical intervention was once the mainstay of treatment for Buruli ulcer disease, a neglected tropical disease caused by Mycobacterium ulcerans. Since the…”
    Get full text
    Journal Article
  14. 14

    Blood eosinophilia as a marker of early and late treatment failure in severe acute exacerbations of COPD by Prins, Hendrik J., Duijkers, Ruud, Lutter, Rene, Daniels, Johannes M., van der Valk, Paul, Schoorl, Margreet, Kerstjens, Huib A., van der Werf, Tjip S., Boersma, Wim G.

    Published in Respiratory medicine (01-10-2017)
    “…Blood eosinophilia is frequently encountered in patients with AECOPD. However the impact of blood eosinophilia at admission in patients with AECOPD on outcome…”
    Get full text
    Journal Article
  15. 15

    Association between Faecalibacterium prausnitzii and dietary fibre in colonic fermentation in healthy human subjects by Benus, Robin F. J., van der Werf, Tjip S., Welling, Gjalt W., Judd, Patricia A., Taylor, Moira A., Harmsen, Hermie J. M., Whelan, Kevin

    Published in British journal of nutrition (14-09-2010)
    “…The intestinal microbiota are a complex ecosystem influencing the immunoregulation of the human host, providing protection from colonising pathogens and…”
    Get full text
    Journal Article
  16. 16

    Linezolid tolerability in multidrug-resistant tuberculosis: a retrospective study by Bolhuis, Mathieu S, Tiberi, Simon, Sotgiu, Giovanni, De Lorenzo, Saverio, Kosterink, Jos G W, van der Werf, Tjip S, Migliori, Giovanni Battista, Alffenaar, Jan-Willem C

    Published in The European respiratory journal (01-10-2015)
    “…Linezolid is used off-label to treat multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) [1, 2]. Recently, two systematic reviews…”
    Get full text
    Journal Article
  17. 17

    Non-Steroidal Anti-inflammatory Drugs As Host-Directed Therapy for Tuberculosis: A Systematic Review by Kroesen, Vera M, Gröschel, Matthias I, Martinson, Neil, Zumla, Alimuddin, Maeurer, Markus, van der Werf, Tjip S, Vilaplana, Cristina

    Published in Frontiers in immunology (30-06-2017)
    “…Lengthy, antimicrobial therapy targeting the pathogen is the mainstay of conventional tuberculosis treatment, complicated by emerging drug resistances…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Long term streptomycin toxicity in the treatment of Buruli Ulcer: follow-up of participants in the BURULICO drug trial by Klis, Sandor, Stienstra, Ymkje, Phillips, Richard O, Abass, Kabiru Mohammed, Tuah, Wilson, van der Werf, Tjip S

    Published in PLoS neglected tropical diseases (01-03-2014)
    “…Buruli Ulcer (BU) is a tropical infectious skin disease that is currently treated with 8 weeks of intramuscular streptomycin and oral rifampicin. As prolonged…”
    Get full text
    Journal Article